Numab partners with Sucampo's Sucampo AG subsidiary to discover and develop antibodies against up to four undisclosed targets

Numab AG

Switzerland / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sucampo Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$139.8m on 09/16/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced